|1|FOXA1 expression after neoadjuvant chemotherapy is a prognostic marker in estrogen receptor-positive breast cancer. (23771556)
Kawase M.... Yamashita H.
|2|Breast cancer index identifies early-stage estrogen receptor-positive breast cancer patients at risk for early- and late-distant recurrence. (23757354)
Zhang Y.... Erlander M.G.
|3|p53 accumulation is a strong predictor of recurrence in estrogen receptor-positive breast cancer patients treated with aromatase inhibitors. (24118529)
Yamamoto M.... Yamashita H.
|4|BCL-2: a new therapeutic target in estrogen receptor-positive breast cancer? (23845438)
Martin L.A.... Dowsett M.
|5|Prognostic discrimination using a 70-gene signature among patients with estrogen receptor-positive breast cancer and an intermediate 21-gene recurrence score. (24304542)
Ahn S.G.... Chu I.S.
|6|Tannic Acid preferentially targets estrogen receptor-positive breast cancer. (24369505)
Booth B.W.... Burg K.J.
|7|Pregnancy after a diagnosis of estrogen receptor-positive breast cancer does not affect prognosis. (23463611)
|8|Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. (23971947)
Hefti M.M.... Beck A.H.
|9|G protein-coupled estrogen receptor is apoptotic and correlates with increased distant disease-free survival of estrogen receptor-positive breast cancer patients. (23554355)
Broselid S.... Leeb-Lundberg L.M.
|10|p53, a target of estrogen receptor (ER) I+, modulates DNA damage-induced growth suppression in ER-positive breast cancer cells. (22787161)
Berger C.E.... Chen X.
|11|Hazard of breast cancer-specific mortality among women with estrogen receptor-positive breast cancer after five years from diagnosis: implication for extended endocrine therapy. (22993034)
Yu K.D.... Shao Z.M.
|12|Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24. (22393101)
Allred D.C.... Wolmark N.
|13|Mouse models of estrogen receptor-positive breast cancer. (22279420)
Mohibi S.... Band V.
|14|Estrogen receptor-positive breast cancer in Japanese women: trends in incidence, characteristics, and prognosis. (21119029)
Yamashita H.... Kobayashi S.
|15|Physician survey of the effect of the 21-gene recurrence score assay results on treatment recommendations for patients with lymph node-positive, estrogen receptor-positive breast cancer. (21731516)
Oratz R.... Broder M.
|16|SLC6A14 (ATB0,+) protein, a highly concentrative and broad specific amino acid transporter, is a novel and effective drug target for treatment of estrogen receptor-positive breast cancer. (21771784)
Karunakaran S.... Ganapathy V.
|17|Effects of SDF-1-CXCR4 signaling on microRNA expression and tumorigenesis in estrogen receptor-alpha (ER-I+)-positive breast cancer cells. (21906588)
Rhodes L.V.... Burow M.E.
|18|Estrogen up-regulates ATBF1 transcription but causes its protein degradation in estrogen receptor-alpha-positive breast cancer cells. (21367855)
Dong X.Y.... Dong J.T.
|19|Estrogen receptor (ESR1) mRNA expression and benefit from tamoxifen in the treatment and prevention of estrogen receptor-positive breast cancer. (21947828)
Kim C.... Paik S.
|20|Risk of recurrence and chemotherapy benefit for patients with node-negative, estrogen receptor-positive breast cancer: recurrence score alone and integrated with pathologic and clinical factors. (22010013)
Tang G.... Wolmark N.
|21|Estrogen-induced interaction between KLF5 and estrogen receptor (ER) suppresses the function of ER in ER-positive breast cancer cells. (19569049)
Guo P.... Dong J.T.
|22|The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells. (20086172)
Ariazi E.A.... Jordan V.C.
|23|Relationship between plasma estradiol levels and estrogen-responsive gene expression in estrogen receptor-positive breast cancer in postmenopausal women. (20124184)
Dunbier A.K.... Dowsett M.
|24|High CCND1 amplification identifies a group of poor prognosis women with estrogen receptor positive breast cancer. (19904758)
Roy P.G.... Thompson A.M.
|25|PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancer. (20479250)
Loi S.... Sotiriou C.
|26|Growth inhibition of estrogen receptor positive human breast cancer cells by Taheebo from the inner bark of Tabebuia avellandae tree. (19578798)
Mukherjee B.... Wong G.Y.
|27|PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro. (19874578)
Finn R.S.... Slamon D.J.
|28|Does breast density show difference in patients with estrogen receptor-positive and estrogen receptor-negative breast cancer measured on MRI? (19654204)
Chen J.H.... Su M.Y.
|29|Gene expression profiling identifies activated growth factor signaling in poor prognosis (Luminal-B) estrogen receptor positive breast cancer. (19552798)
Loi S.... McArthur G.A.
|30|Estrogen induces estrogen-related receptor alpha gene expression and chromatin structural changes in estrogen receptor (ER)-positive and ER-negative breast cancer cells. (18174157)
Hu P.... Teng C.
|31|Possible difference in frequencies of genetic polymorphisms of estrogen receptor alpha, estrogen metabolism and P53 genes between estrogen receptor-positive and -negative breast cancers. (18820009)
Hamaguchi M.... Yamashita H.
|32|Arylamine N-acetyltransferase 1 expression in breast cancer cell lines: a potential marker in estrogen receptor-positive tumors. (17973251)
Wakefield L.... Sim E.
|33|Modulation of cell cycles and apoptosis by apicidin in estrogen receptor (ER)-positive and-negative human breast cancer cells. (18313654)
Im J.Y.... Kim H.S.
|34|Neoadjuvant letrozole in postmenopausal estrogen and/or progesterone receptor positive breast cancer: a phase IIb/III trial to investigate optimal duration of preoperative endocrine therapy. (18302747)
Krainick-Strobel U.E.... Paepke S.
|35|Effect of molecular disease subsets on disease-free survival in randomized adjuvant chemotherapy trials for estrogen receptor-positive breast cancer. (18662965)
Pusztai L.... Hortobagyi G.N.
|36|Combined paclitaxel and cetuximab achieved a major response on the skin metastases of a patient with epidermal growth factor receptor-positive, estrogen receptor-negative, progesterone receptor-negative and human epidermal growth factor receptor-2-negative (triple-negative) breast cancer. (17581308)
Gholam D.... Jasmin C.
|37|Mechanism of and requirement for estrogen-regulated MYB expression in estrogen-receptor-positive breast cancer cells. (17690249)
Drabsch Y.... Gonda T.J.
|38|Progesterone receptor in estrogen receptor-positive breast cancer: the association between HER-2 and lymph node involvement is age related. (16735717)
Neven P.... Vergote I.
|39|Estrogen enhances the efficacy of an oncolytic HSV-1 mutant in the treatment of estrogen receptor-positive breast cancer. (16685445)
Stiles B.M.... Fong Y.
|40|Estrogen regulation of the glucuronidation enzyme UGT2B15 in estrogen receptor-positive breast cancer cells. (16690804)
Harrington W.R.... Katzenellenbogen B.S.
|41|Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. (16720680)
Paik S.... Wolmark N.
|42|Stat5 expression predicts response to endocrine therapy and improves survival in estrogen receptor-positive breast cancer. (16954437)
Yamashita H.... Iwase H.
|43|Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer. (15806142)
Saji S.... Toi M.
|44|In vivo prediction of response to antiestrogen treatment in estrogen receptor-positive breast cancer. (14734659)
Bennink R.J.... Sloof G.W.
|45|Association of p53 genetic polymorphism (Arg72Pro) with estrogen receptor positive breast cancer risk in Japanese women. (15183535)
Noma C.... Noguchi S.
|46|Combined vascular endothelial growth factor and TP53 status predicts poor response to tamoxifen therapy in estrogen receptor-positive advanced breast cancer. (12684392)
Berns E.M.... Foekens J.A.
|47|Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells. (12444551)
Bindels E.M.... Michalides R.
|48|Heat shock proteins hsp27 and hsp70: lack of correlation with response to tamoxifen and clinical course of disease in estrogen receptor-positive metastatic breast cancer (a Southwest Oncology Group Study). (9607585)
Ciocca D.R.... Osborne C.K.
|49|Influence of different combinations of tamoxifen and toremifene on estrogen receptor-positive breast cancer cell lines. (7553677)
Coradini D.... Di Fronzo G.
|50|Endocrine versus endocrine plus five-drug chemotherapy in postmenopausal women with stage II estrogen receptor-positive breast cancer. (2790695)
Pearson O.H.... McGuire W.